Abstract B008: Decoding the primary site-specific regulation of rhabdomyosarcoma metastasis

Abstract The prognosis for patients with high-risk rhabdomyosarcoma (RMS), a pediatric sarcoma characterized in part by defective skeletal muscle (myogenic) differentiation, has remained stagnant at <30% for over forty years. With >15% of patients presenting at diagnosis with metastasis, a defining factor of high-risk disease, there is an urgent need for new therapies. Some primary tumor locations are associated with a higher incidence of metastasis and poorer outcomes. However, the biology (and potential for therapeutic intervention) driving this prognostic factor is poorly defined.To analyze the influence of the primary tumor location on RMS invasion and metastasis, we evaluated cell line xenografts (CDX) implanted in a favorable site, the tongue, versus an unfavorable site, the hindlimb. We evaluated invasion and metastasis from each primary tumor site by histopathology and measured gene expression changes by bulk RNAseq.Despite the tongue being deemed a favorable primary site, perineural invasion or intravascular tumor emboli (60% versus 0%), sentinel lymph node metastasis (25-100% versus 0%), and clinically significant lung metastases (>10% lung area or symptomatic mice; 20% versus 0%) were observed more frequently in tongue xenograft-bearing mice than hindlimb xenograft-bearing mice. The expression of myogenic differentiation markers is higher in tongue CDX than in hindlimb CDX, but expression of these markers is reduced upon metastasis. These phenotypes are maintained when cells are returned to 2D culture, suggesting a stable shift in the differentiation state. Interestingly, CDX of sentinel lymph node metastasis-derived cells were more invasive and metastatic than parental CDX when implanted in the tongue, but not when implanted in the hindlimb.Our work, the first direct evaluation of RMS invasion and metastasis by primary tumor location, demonstrates that the primary tumor location influences RMS metastasis and that tumor cell-intrinsic properties alone are insufficient to increase invasion and metastasis. Ongoing work aims to identify the mechanisms by which the primary tumor microenvironment regulates invasion, enhancing our understanding of the biology of RMS metastasis and offering an opportunity to employ a precision medicine-based approach to targeting metastasis. Citation Format: Katie E. Hebron, Kristine Isanogle, Elijah F. Edmondson, Amy James, Simone Difilippantonio, Marielle E. Yohe. Decoding the primary site-specific regulation of rhabdomyosarcoma metastasis [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Pediatric Cancer Research; 2024 Sep 5-8; Toronto, Ontario, Canada. Philadelphia (PA): AACR; Cancer Res 2024;84(17 Suppl):Abstract nr B008.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2024-09-05
DOI
https://doi.org/10.1158/1538-7445.pediatric24-b008
Primary Topic
Sarcoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract B008: Decoding the primary site-specific regulation of rhabdomyosarcoma metastasis

Marielle E. Yohe, Kristine A. Isanogle, Katie E. Hebron, Elijah F. Edmondson et al.
Cancer Research
Sarcoma Diagnosis and Treatment
article

Abstract B008: Decoding the primary site-specific regulation of rhabdomyosarcoma metastasis

Marielle E. Yohe, Kristine A. Isanogle, Katie E. Hebron, Elijah F. Edmondson, Simone Difilippantonio, Amy James
article en

Abstract

Abstract The prognosis for patients with high-risk rhabdomyosarcoma (RMS), a pediatric sarcoma characterized in part by defective skeletal muscle (myogenic) differentiation, has remained stagnant at <30% for over forty years. With >15% of patients presenting at diagnosis with metastasis, a defining factor of high-risk disease, there is an urgent need for new therapies. Some primary tumor locations are associated with a higher incidence of metastasis and poorer outcomes. However, the biology (and potential for therapeutic intervention) driving this prognostic factor is poorly defined.To analyze the influence of the primary tumor location on RMS invasion and metastasis, we evaluated cell line xenografts (CDX) implanted in a favorable site, the tongue, versus an unfavorable site, the hindlimb. We evaluated invasion and metastasis from each primary tumor site by histopathology and measured gene expression changes by bulk RNAseq.Despite the tongue being deemed a favorable primary site, perineural invasion or intravascular tumor emboli (60% versus 0%), sentinel lymph node metastasis (25-100% versus 0%), and clinically significant lung metastases (>10% lung area or symptomatic mice; 20% versus 0%) were observed more frequently in tongue xenograft-bearing mice than hindlimb xenograft-bearing mice. The expression of myogenic differentiation markers is higher in tongue CDX than in hindlimb CDX, but expression of these markers is reduced upon metastasis. These phenotypes are maintained when cells are returned to 2D culture, suggesting a stable shift in the differentiation state. Interestingly, CDX of sentinel lymph node metastasis-derived cells were more invasive and metastatic than parental CDX when implanted in the tongue, but not when implanted in the hindlimb.Our work, the first direct evaluation of RMS invasion and metastasis by primary tumor location, demonstrates that the primary tumor location influences RMS metastasis and that tumor cell-intrinsic properties alone are insufficient to increase invasion and metastasis. Ongoing work aims to identify the mechanisms by which the primary tumor microenvironment regulates invasion, enhancing our understanding of the biology of RMS metastasis and offering an opportunity to employ a precision medicine-based approach to targeting metastasis. Citation Format: Katie E. Hebron, Kristine Isanogle, Elijah F. Edmondson, Amy James, Simone Difilippantonio, Marielle E. Yohe. Decoding the primary site-specific regulation of rhabdomyosarcoma metastasis [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Pediatric Cancer Research; 2024 Sep 5-8; Toronto, Ontario, Canada. Philadelphia (PA): AACR; Cancer Res 2024;84(17 Suppl):Abstract nr B008.

Cancer ResearchVol. 84(17_Supplement)
National Cancer Institute (US)
Openalex Percentile: Top 73%
Sarcoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.